TY - JOUR
T1 - Conduction dynamics over time after transcatheter aortic valve replacement
T2 - An expert review
AU - Kroon, Herbert G.
AU - Hokken, Thijmen
AU - van Wiechen, Maarten
AU - Ooms, Joris F.W.
AU - van Gils, Lennart
AU - Kardys, Isabella
AU - Daemen, Joost
AU - De Jaegere, Peter P.T.
AU - Nuis, Rutger Jan
AU - Van Mieghem, Nicolas M.
N1 - Publisher Copyright:
© 2024
PY - 2025/1
Y1 - 2025/1
N2 - New conduction disorders remain a frequent complication in current transcatheter aortic valve replacement (TAVR) era. Left bundle branch block (LBBB) occurs early in about 20–30 % of TAVR-patients, persists at 1 month in about 35–45 % of cases and will likely remain thereafter. Third-degree atrioventricular block (AV3B) affects approximately 15 % of patients. Pacemaker dependency gradually decreases throughout follow-up and approximately 25–35 % of patients remain pacemaker dependent at one year. We aimed to review what is currently known about the dynamics of acquired conduction disorders, including extraction of predictors, and how to interpret these dynamics in light of an early discharge policy.
AB - New conduction disorders remain a frequent complication in current transcatheter aortic valve replacement (TAVR) era. Left bundle branch block (LBBB) occurs early in about 20–30 % of TAVR-patients, persists at 1 month in about 35–45 % of cases and will likely remain thereafter. Third-degree atrioventricular block (AV3B) affects approximately 15 % of patients. Pacemaker dependency gradually decreases throughout follow-up and approximately 25–35 % of patients remain pacemaker dependent at one year. We aimed to review what is currently known about the dynamics of acquired conduction disorders, including extraction of predictors, and how to interpret these dynamics in light of an early discharge policy.
UR - http://www.scopus.com/inward/record.url?scp=85204248242&partnerID=8YFLogxK
U2 - 10.1016/j.carrev.2024.08.005
DO - 10.1016/j.carrev.2024.08.005
M3 - Review article
C2 - 39299841
AN - SCOPUS:85204248242
SN - 1553-8389
VL - 70
SP - 92
EP - 102
JO - Cardiovascular Revascularization Medicine
JF - Cardiovascular Revascularization Medicine
ER -